Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
Read More Healthcare Industry News CooperCompanies Q2 FY2025 results: Revenue tops $1bn, but stock hits 52-week low Despite 14% EPS growth and a strong lens and surgical portfolio, CooperCompanies stock falls to 52-week low. Find out what’s driving investor sentiment. byPallavi MadhirajuMay 30, 2025